NASA's supercomputer is now being used to find a cure for the coronavirus.
Pic-Of-Super-Computer |
Washington: The White House has formed a consortium of public and
private companies that will support research into the treatment and vaccine for
the coronavirus. The supercomputer is located at NASA's Research Center in
Northern California.
A consortium of the American government and private industry is using
the supercomputer to fight the coronavirus. This supercomputer is trying to
find out how the virus connects to cells in the human body and how much genetic
involvement is involved in it and what kind of drugs can be made to treat this
disease.
The White House Office of Science and Technology Policy says it includes
private companies such as IBM, Hewlett-Packard Enterprise, Amazon, Microsoft,
and others. The National Laboratories of the Department of Energy, the National Science Foundation, and several universities are also working with them.
The consortium will examine the coronavirus from a supercomputer. NASA's
supercomputer is installed at the Ames Research Center in Northern California.
It is commonly used for land and space projects. Using it, national priorities
are put forward.
Supercomputers can analyze large amounts of data, which is why it is so
crucial in NASA's ongoing projects. For example, planets outside our solar
system are explored, as well as black holes. The same computer is also used to
design air and space vehicles.
So the supercomputer's capabilities for research on the coronavirus
will be exploited. To do this, copies of the coronavirus will be artificially
inserted into a computer to see how the coronavirus reacts at the cellular and
molecular levels.
So far, NASA computers have been able to determine the genetic predisposition to the virus's difficulty breathing. The idea is that if this
connection is known, then a cure for this disease can be developed. The study
will also identify biomarkers related to the coronavirus, how they react
inside the human body, and what effects it produces.
0 Comments